Mozaffari, E., Chandak, A., Gottlieb, R. L., Chima-Melton, C., Berry, M., Oppelt, T., Okulicz, J. F., Amin, A. N., Welte, T., Sax, P. E., & Kalil, A. C. Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciae477. Advance online publication. https://doi.org/10.1093/cid/ciae477
